HomeFinanceFinanceBoston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clotsBy iaqamar84@gmail.comJanuary 15, 2026014FacebookTwitterPinterestWhatsApp Penumbra’s stock was up about 12% after the deal was announced Thursday morning.TagsBillionbloodBostonbusinessbuyingclotsPenumbraremovingScientificShareFacebookTwitterPinterestWhatsApp Previous articleFed’s Goolsbee says inflation could come ‘roaring back’ if central bank independence goes awayNext articleThe next Subway Surfers game comes out in Februaryiaqamar84@gmail.comhttp://gainpassive.comRelated Articles TechTurboTax Deluxe is on sale for $45 ahead of tax season FinanceSyria tightens grip after Kurdish pullback, says IS prisoners escape TechThe Biggest Aurora of 2026 (So Far) Is Coming Tonight: Here’s How and Where to See It LEAVE A REPLY Cancel replyComment:Please enter your comment! Name:*Please enter your name here Email:*You have entered an incorrect email address!Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. Latest Articles TechTurboTax Deluxe is on sale for $45 ahead of tax season FinanceSyria tightens grip after Kurdish pullback, says IS prisoners escape TechThe Biggest Aurora of 2026 (So Far) Is Coming Tonight: Here’s How and Where to See It FinancePowell to attend Supreme Court on Trump bid to fire Lisa Cook TechThe Role of AI in Finance, Insurance, and Real Estate Decision-MakingLoad more
